AAAAAA

   
Results: 1-8 |
Results: 8
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models
Authors: Szczepankiewicz, BG Liu, G Jae, HS Tasker, AS Gunawardana, IW von Geldern, TW Gwaltney, SL Wu-Wong, JR Gehrke, L Chiou, WJ Credo, RB Alder, JD Nukkala, MA Zielinski, NA Jarvis, K Mollison, KW Frost, DJ Bauch, JL Hui, YH Claiborne, AK Li, Q Rosenberg, SH
Citation: Bg. Szczepankiewicz et al., New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models, J MED CHEM, 44(25), 2001, pp. 4416-4430
3,5-bis(trifluoromethyl)pyrazoles: A novel class of NFAT transcription factor regulator
Authors: Djuric, SW BaMaung, NY Basha, A Liu, HQ Luly, JR Madar, DJ Sciotti, RJ Tu, NP Wagenaar, FL Wiedeman, PE Zhou, X Ballaron, S Bauch, J Chen, YW Chiou, XG Fey, T Gauvin, D Gubbins, E Hsieh, GC Marsh, KC Mollison, KW Pong, M Shaughnessy, TK Sheets, MP Smith, M Trevillyan, JM Warrior, U Wegner, CD Carter, GW
Citation: Sw. Djuric et al., 3,5-bis(trifluoromethyl)pyrazoles: A novel class of NFAT transcription factor regulator, J MED CHEM, 43(16), 2000, pp. 2975-2981
Ex vivo assessment of immunosuppression in undiluted whole blood from pigsdosed with tacrolimus (FK506)
Authors: Chen, YW Smith, ML Sheets, MP Ballaron, SJ Trevillyan, JM Fey, TA Gauvin, DM Kolano, R Pong, MS Hsieh, GC Bauch, J Marsh, K Carter, G Luly, J Djuric, S Mollison, KW
Citation: Yw. Chen et al., Ex vivo assessment of immunosuppression in undiluted whole blood from pigsdosed with tacrolimus (FK506), CLIN IMMUNO, 90(1), 1999, pp. 133-140
Development of a p38 kinase binding assay for high throughput screening
Authors: Warrior, U Chiou, XG Sheets, MP Sciotti, RJ Parry, JM Simmer, RL Surber, BW Burns, DJ Beutel, BA Mollison, KW Djuric, SW Trevillyan, JM
Citation: U. Warrior et al., Development of a p38 kinase binding assay for high throughput screening, J BIOMOL SC, 4(3), 1999, pp. 129-135
Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin
Authors: Burke, SE Lubbers, NL Chen, YW Hsieh, GC Mollison, KW Luly, JR Wegner, CD
Citation: Se. Burke et al., Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin, J CARDIO PH, 33(6), 1999, pp. 829-835
Retention of immunosuppressant activity in an ascomycin analogue lacking ahydrogen-bonding interaction with FKBP12
Authors: Wiedeman, PE Fesik, SW Petros, AM Nettesheim, DG Mollison, KW Lane, BC Or, YS Luly, JR
Citation: Pe. Wiedeman et al., Retention of immunosuppressant activity in an ascomycin analogue lacking ahydrogen-bonding interaction with FKBP12, J MED CHEM, 42(21), 1999, pp. 4456-4461
A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseases
Authors: Mollison, KW Fey, TA Gauvin, DM Kolano, RM Sheets, MP Smith, ML Pong, M Nikolaidis, NM Lane, BC Trevillyan, JM Cannon, J Marsh, K Carter, GW Or, YS Chen, YW Hsieh, GC Luly, JR
Citation: Kw. Mollison et al., A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseases, J INVES DER, 112(5), 1999, pp. 729-738
Inhibition of p56(lck) tyrosine kinase by isothiazolones
Authors: Trevillyan, JM Chiou, XG Ballaron, SJ Tang, QM Buko, A Sheets, MP Smith, ML Putman, CB Wiedeman, P Tu, N Madar, D Smith, HT Gubbins, EJ Warrior, UP Chen, YW Mollison, KW Faltynek, CR Djuric, SW
Citation: Jm. Trevillyan et al., Inhibition of p56(lck) tyrosine kinase by isothiazolones, ARCH BIOCH, 364(1), 1999, pp. 19-29
Risultati: 1-8 |